234 related articles for article (PubMed ID: 19781375)
1. Expression of programmed death 1 and its ligands in the liver of autoimmune hepatitis C57BL/6 mice.
Cao J; Liu FX; Yu MX
Chin Med J (Engl); 2009 Aug; 122(16):1941-6. PubMed ID: 19781375
[TBL] [Abstract][Full Text] [Related]
2. Intrahepatic expression of the co-stimulatory molecules programmed death-1, and its ligands in autoimmune liver disease.
Oikawa T; Takahashi H; Ishikawa T; Hokari A; Otsuki N; Azuma M; Zeniya M; Tajiri H
Pathol Int; 2007 Aug; 57(8):485-92. PubMed ID: 17610472
[TBL] [Abstract][Full Text] [Related]
3. CD4+PD-1+ T cells acting as regulatory cells during the induction of anterior chamber-associated immune deviation.
Meng Q; Yang P; Li B; Zhou H; Huang X; Zhu L; Ren Y; Kijlstra A
Invest Ophthalmol Vis Sci; 2006 Oct; 47(10):4444-52. PubMed ID: 17003438
[TBL] [Abstract][Full Text] [Related]
4. PD-1-PD-L1 pathway is involved in suppressing alloreactivity of heart infiltrating t cells during murine gvhd across minor histocompatibility antigen barriers.
Schilbach K; Schick J; Wehrmann M; Wollny G; Simon P; Schlegel PG; Eyrich M
Transplantation; 2007 Jul; 84(2):214-22. PubMed ID: 17667813
[TBL] [Abstract][Full Text] [Related]
5. Regulation of PD-1, PD-L1, and PD-L2 expression during normal and autoimmune responses.
Liang SC; Latchman YE; Buhlmann JE; Tomczak MF; Horwitz BH; Freeman GJ; Sharpe AH
Eur J Immunol; 2003 Oct; 33(10):2706-16. PubMed ID: 14515254
[TBL] [Abstract][Full Text] [Related]
6. PD-L1 partially protects renal tubular epithelial cells from the attack of CD8+ cytotoxic T cells.
Waeckerle-Men Y; Starke A; Wüthrich RP
Nephrol Dial Transplant; 2007 Jun; 22(6):1527-36. PubMed ID: 17339272
[TBL] [Abstract][Full Text] [Related]
7. Blockade of B7-H1 with sPD-1 improves immunity against murine hepatocarcinoma.
He L; Zhang G; He Y; Zhu H; Zhang H; Feng Z
Anticancer Res; 2005; 25(5):3309-13. PubMed ID: 16101143
[TBL] [Abstract][Full Text] [Related]
8. PD-L1 is expressed by human renal tubular epithelial cells and suppresses T cell cytokine synthesis.
Ding H; Wu X; Gao W
Clin Immunol; 2005 May; 115(2):184-91. PubMed ID: 15885642
[TBL] [Abstract][Full Text] [Related]
9. T-cell suppression by programmed cell death 1 ligand 1 on retinal pigment epithelium during inflammatory conditions.
Sugita S; Usui Y; Horie S; Futagami Y; Aburatani H; Okazaki T; Honjo T; Takeuchi M; Mochizuki M
Invest Ophthalmol Vis Sci; 2009 Jun; 50(6):2862-70. PubMed ID: 19182257
[TBL] [Abstract][Full Text] [Related]
10. Expression of PD-1, PD-L1, and PD-L2 in the liver in autoimmune liver diseases.
Mataki N; Kikuchi K; Kawai T; Higashiyama M; Okada Y; Kurihara C; Hokari R; Kawaguchi A; Nagao S; Kondo T; Itoh K; Miyakawa H; Miura S
Am J Gastroenterol; 2007 Feb; 102(2):302-12. PubMed ID: 17311651
[TBL] [Abstract][Full Text] [Related]
11. Interferon-beta enhances monocyte and dendritic cell expression of B7-H1 (PD-L1), a strong inhibitor of autologous T-cell activation: relevance for the immune modulatory effect in multiple sclerosis.
Schreiner B; Mitsdoerffer M; Kieseier BC; Chen L; Hartung HP; Weller M; Wiendl H
J Neuroimmunol; 2004 Oct; 155(1-2):172-82. PubMed ID: 15342209
[TBL] [Abstract][Full Text] [Related]
12. Blockade of the interaction between PD-1 and PD-L1 accelerates graft arterial disease in cardiac allografts.
Koga N; Suzuki J; Kosuge H; Haraguchi G; Onai Y; Futamatsu H; Maejima Y; Gotoh R; Saiki H; Tsushima F; Azuma M; Isobe M
Arterioscler Thromb Vasc Biol; 2004 Nov; 24(11):2057-62. PubMed ID: 15374847
[TBL] [Abstract][Full Text] [Related]
13. IFN-gamma and TNF-alpha differentially regulate immunomodulation by murine mesenchymal stem cells.
English K; Barry FP; Field-Corbett CP; Mahon BP
Immunol Lett; 2007 Jun; 110(2):91-100. PubMed ID: 17507101
[TBL] [Abstract][Full Text] [Related]
14. Role of the programmed Death-1 pathway in the suppressive activity of alternatively activated macrophages in experimental cysticercosis.
Terrazas LI; Montero D; Terrazas CA; Reyes JL; Rodríguez-Sosa M
Int J Parasitol; 2005 Nov; 35(13):1349-58. PubMed ID: 16126211
[TBL] [Abstract][Full Text] [Related]
15. PD-L2 is a second ligand for PD-1 and inhibits T cell activation.
Latchman Y; Wood CR; Chernova T; Chaudhary D; Borde M; Chernova I; Iwai Y; Long AJ; Brown JA; Nunes R; Greenfield EA; Bourque K; Boussiotis VA; Carter LL; Carreno BM; Malenkovich N; Nishimura H; Okazaki T; Honjo T; Sharpe AH; Freeman GJ
Nat Immunol; 2001 Mar; 2(3):261-8. PubMed ID: 11224527
[TBL] [Abstract][Full Text] [Related]
16. Preferential contribution of B7-H1 to programmed death-1-mediated regulation of hapten-specific allergic inflammatory responses.
Tsushima F; Iwai H; Otsuki N; Abe M; Hirose S; Yamazaki T; Akiba H; Yagita H; Takahashi Y; Omura K; Okumura K; Azuma M
Eur J Immunol; 2003 Oct; 33(10):2773-82. PubMed ID: 14515261
[TBL] [Abstract][Full Text] [Related]
17. Interaction of PD-L1 on tumor cells with PD-1 on tumor-specific T cells as a mechanism of immune evasion: implications for tumor immunotherapy.
Blank C; Gajewski TF; Mackensen A
Cancer Immunol Immunother; 2005 Apr; 54(4):307-14. PubMed ID: 15599732
[TBL] [Abstract][Full Text] [Related]
18. The expression of B7-H1 on keratinocytes in chronic inflammatory mucocutaneous disease and its regulatory role.
Youngnak-Piboonratanakit P; Tsushima F; Otsuki N; Igarashi H; Machida U; Iwai H; Takahashi Y; Omura K; Yokozeki H; Azuma M
Immunol Lett; 2004 Jul; 94(3):215-22. PubMed ID: 15275969
[TBL] [Abstract][Full Text] [Related]
19. PD-L1 and PD-L2 are differentially regulated by Th1 and Th2 cells.
Loke P; Allison JP
Proc Natl Acad Sci U S A; 2003 Apr; 100(9):5336-41. PubMed ID: 12697896
[TBL] [Abstract][Full Text] [Related]
20. Triptolide inhibits B7-H1 expression on proinflammatory factor activated renal tubular epithelial cells by decreasing NF-kappaB transcription.
Chen Y; Zhang J; Li J; Zhao T; Zou L; Tang Y; Zhang X; Wu Y
Mol Immunol; 2006 Mar; 43(8):1088-98. PubMed ID: 16129490
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
